Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alberto Verrotti is active.

Publication


Featured researches published by Alberto Verrotti.


Diabetes Care | 1998

Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.

Lucio Lobefalo; Alberto Verrotti; Leonardo Mastropasqua; G Della Loggia; V Cherubini; Guido Morgese; Pier Enrico Gallenga; Francesco Chiarelli

OBJECTIVE: We compared blue-on-yellow perimetry with achromatic perimetry to determine whether the first was more sensitive in detecting visual field defects. RESEARCH DESIGN AND METHODS: We studied 50 children and adolescents (22 male, 28 female) with IDDM, ranging in age from 10.1 to 16.3 years (mean 13.3+/-2.1 years), with a disease duration of 5.2-10.0 years (mean 7.1+/-1.9 years). Patients were divided into subgroups according to the presence of persistent microalbuminuria. No one had signs of diabetic retinopathy when studied with fluorescein angiography. RESULTS: By achromatic perimetry, the analysis of subareas of the central 30 degrees of the visual field (0-9 degrees; 10-18 degrees; out of 18 degrees) showed no differences between diabetic subgroups in the central 18 degrees of the visual field, while a significant difference between the same subgroups was found outside the 18 degrees of the 24-2 program of the Humphrey perimeter (P = 0.027). By blue-on-yellow perimetry, in all three of the perimetric subareas evaluated, the sensitivity was lower in microalbuminuric patients than in normoalbuminuric ones. The differential sensitivity between the perimetric tests performed with blue-on-yellow and with achromatic stimuli showed statistically significant data, with a higher level of significance in the central 18 degrees (P < 0.0001) than outside the 18 degrees (P = 0.033). CONCLUSIONS: Our study suggests that blue-on-yellow perimetry is more useful and more sensitive than achromatic perimetry in the detection of preclinical visual field defects in diabetic children with microalbuminuria but without clinically detectable retinopathy.


Developmental Medicine & Child Neurology | 2000

Visual evoked potentials in young persons with newly diagnosed diabetes: a long‐term follow‐up

Alberto Verrotti; Lucio Lobefalo; Daniela Trotta; Giuseppe Della Loggia; Francesco Chiarelli; Colangelo Luigi; Guido Morgese; Pierenrico Gallenga

To evaluate the presence of electrophysiological abnormalities in the visual function of young persons with diabetes, visual evoked potentials were recorded, in basal conditions and after photostress, in 30 patients with newly diagnosed insulin‐dependent diabetes mellitus. Their mean age was 17.6 years (3.6 SD), and their glycosated haemoglobin (HbA1c) was 9.4% (1.6 SD). Thirty healthy age‐ and sex‐matched individuals were evaluated as the control group. This study showed that the P100 latency was significantly delayed in patients with diabetes compared with the control group (p<0.01), while the N75 to P100 amplitude was similar in both groups. These measurements were repeated after 6 months, when all participants with diabetes had achieved good metabolic control (HbA1c 7.2% [1.5 SD]). At this second evaluation a complete normalisation of all parameters was observed. These findings suggest that early functional abnormalities of the optic nerve can be detected at onset of diabetes, and that glycaemic control reverses these abnormalities.


Pediatric Research | 1999

BLUE-ON-YELLOW AND ACHROMATIC PERIMETRY IN DIABETIC CHILDREN WITHOUT RETINOPATHY

Lucio Lobefalo; Alberto Verrotti; L. Colangelo; Daniela Trotta; R Di Crescenzo; V Matera; Leonardo Mastropasqua; G. Della Loggia; Francesco Chiarelli

OBJECTIVE We compared blue-on-yellow perimetry with achromatic perimetry to determine whether the first was more sensitive in detecting visual field defects. RESEARCH DESIGN AND METHODS We studied 50 children and adolescents (22 male, 28 female) with IDDM, ranging in age from 10.1 to 16.3 years (mean 13.3+/-2.1 years), with a disease duration of 5.2-10.0 years (mean 7.1+/-1.9 years). Patients were divided into subgroups according to the presence of persistent microalbuminuria. No one had signs of diabetic retinopathy when studied with fluorescein angiography. RESULTS By achromatic perimetry, the analysis of subareas of the central 30 degrees of the visual field (0-9 degrees; 10-18 degrees; out of 18 degrees) showed no differences between diabetic subgroups in the central 18 degrees of the visual field, while a significant difference between the same subgroups was found outside the 18 degrees of the 24-2 program of the Humphrey perimeter (P = 0.027). By blue-on-yellow perimetry, in all three of the perimetric subareas evaluated, the sensitivity was lower in microalbuminuric patients than in normoalbuminuric ones. The differential sensitivity between the perimetric tests performed with blue-on-yellow and with achromatic stimuli showed statistically significant data, with a higher level of significance in the central 18 degrees (P < 0.0001) than outside the 18 degrees (P = 0.033). CONCLUSIONS Our study suggests that blue-on-yellow perimetry is more useful and more sensitive than achromatic perimetry in the detection of preclinical visual field defects in diabetic children with microalbuminuria but without clinically detectable retinopathy.


Diabetes Nutrition & Metabolism | 1999

Growth hormone and IGF-I in diabetic children with and without microalbuminuria

Alberto Verrotti; Cieri F; Petitti Mt; Guido Morgese; Francesco Chiarelli


Diabetes Nutrition & Metabolism | 1997

Diabetic retinopathy in childhood and adolescence. Effect of puberty

Lucio Lobefalo; Alberto Verrotti; G. Della Loggia; Guido Morgese; Leonardo Mastropasqua; Francesco Chiarelli; Pier Enrico Gallenga


Archive | 2005

Hypoglycemia in Children and Adolescents with Type 1 Diabetes

Annalisa Blasetti; Alberto Verrotti; G. de Michele; Francesco Chiarelli


55th Annual ESPE | 2016

Triple X Syndrome: An Evaluation of Bone Mineral Status and Metabolism

Stefano Stagi; Perla Scalini; Tommaso Mariarosaria Di; Maria Parpagnoli; Silvia Paci; Fabrizio Masoni; F. Chiarelli; Alberto Verrotti; Silvia Guarducci; Sabrina Giglio; Silvia Romano; Martino Maurizio de


Archive | 2002

Clinical Research Increased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine

Alberto Verrotti; Rita Greco; Giuseppe Latini; Guido Morgese; Francesco Chiarelli


Pediatric Research | 1999

ABNORMAL VISUAL EVOKED POTENTIALS IN NEWLY DIAGNOSED DIABETIC CHILDREN

Alberto Verrotti; Lucio Lobefalo; V Matera; G. Della Loggia; Daniela Trotta; P. Del Gallo; Francesco Chiarelli


Clinical Pediatric Endocrinology | 1997

Growth Hormone and IGF-I Secretion in Girls with Precocious Puberty Treated with Depot GnRH Analogues

Francesco Chiarelli; Alberto Verrotti; Mariano Magrì; Giuseppe Sabatino; Guido Morgese

Collaboration


Dive into the Alberto Verrotti's collaboration.

Top Co-Authors

Avatar

Francesco Chiarelli

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lucio Lobefalo

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Daniela Trotta

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pier Enrico Gallenga

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge